Pyridoxine as Prophylactic Therapy for Palmar-Plantar Erythrodysesthesia Associated with Administration of Pegylated Liposomal Doxorubicin (Caelyx): A Single-Center Experience

Publisher： Karger

E-ISSN： 1423-0232|73|3-4|277-278

ISSN： 0030-2414

Source： Oncology, Vol.73, Iss.3-4, 2008-04, pp. : 277-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m2 Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer

By  

Oncology, Vol. 70, Iss. 2, 2006-05 ,pp. : 141-146

Karger

Access to resources Recommend Favorite

Palmar-Plantar Erythrodysesthesia Associated with Chemotherapy and Its Treatment

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-04 ,pp. : 229-235

Karger

Access to resources Recommend Favorite

Fatal Palmar-Plantar Erythrodysesthesia after Clofarabine and Cytarabine Chemotherapy

By  

Acta Haematologica, Vol. 128, Iss. 3, 2012-08 ,pp. : 151-153

Karger

Access to resources Recommend Favorite

Pegylated Liposomal Doxorubicin (Caelyx®) in Metastatic Breast Cancer: A Community-Based Observation Study

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 147-151

Karger

Access to resources Recommend Favorite

A Dose Escalation Study of Pegylated Liposomal Doxorubicin (Caelyx) in Combination with Capecitabine (Xeloda) in Patients with Refractory Solid Tumors

By  

Oncology, Vol. 69, Iss. 6, 2006-02 ,pp. : 463-469

Karger

Access to resources Recommend Favorite